Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike.

Data is taken at the market close – at 4pm AEDT.

Stocks highlighted in yellow rose after making announcements.

Code Company Price % Volume Market Cap
COY Coppermoly 2.5 108.3 24826111 25526567.868
ANP Antisense Therapeut. 20 60 17982466 71748521.375
TRU Truscreen 16.5 57.1 10235726 37901456.565
DOR Doriemus PLC 6 50 165000 2319325
PWNCA Parkway Minls 0.3 50 2000000 493201.286
NWE Norwest Energy NL 0.8 33.3 261459975 28406802.444
TPD Talon Petroleum 0.4 33.3 193412493 13055368.575
XST Xstate Resources 0.8 33.3 71696658 10867445.388
KEY KEY Petroleum 0.6 33.3 106682396 8855676.567
KTE K2 Energy 5.9 31.1 18500322 13529571.795
SIS Simble Solutions 3.8 31.0 1114519 6909671.428
EGY Energy Tech 15 30.4 26008 19667639.825
LVE Love Group Global 9 30.4 623196 2796857.661
TIG Tigers Realm Coal 1.3 30 6584815 97584926.42
ZEO Zeotech Limited 7 29.6 33156438 75548763.936
HLX Helix Resources 1.4 27.2 34738074 8735319.208
ICI Icandy Interactive 15.5 24 19585200 69557981.125
TAO TAO Commodities 36.5 21.7 973791 25961000.1
PGY Pilot Energy 3.5 20.7 4116797 5994634.776
AVL Aust Vanadium 1.8 20 32971820 43952382.21
EDE Eden Inv 3 20 19786258 51942459.075
FGO Fargo Enterprises 0.3 20 4092784 2964391.7575
GLV Global Oil & Gas 1.2 20 30693074 6536248.06
TAS Tasman Resources 4.8 20 2253404 24445579.12
OVN Oventus Medical 25.5 18.6 142414 34026000

Antisense Therapeutics (ASX:ANP) was the second-biggest winner, rising 60 per cent to 20c.

The mRNA-focused drug developer didn’t announce any news, but was the beneficiary of Morgans initiating coverage yesterday with a speculative buy rating and a 38c price target.

“While considerable trial risk and hurdles remain, we view ANP as one of the best risk/reward plays in the healthcare space given the data produced to date and heading into a catalyst rich 36 month period,” Morgans wrote.

The company is moving to a Phase 2b trial of its potential gene-silencing treatment for non-ambulant boys with Duchenne’s muscular dystrophy.

Kiwi cervical cancer diagnostic company TruScreen (ASX:TRU) advanced for a third day after listing on Wednesday.

On Friday TRU shares rose 57.1 per cent to 16.5.c, up 153 per cent from its 6.5c IPO price.

Code Company Price % Volume Market Cap
COY Coppermoly 2.5 108.3 24826111 25526567.868
ANP Antisense Therapeut. 20 60 17982466 71748521.375
TRU Truscreen 16.5 57.1 10235726 37901456.565
DOR Doriemus PLC 6 50 165000 2319325
PWNCA Parkway Minls 0.3 50 2000000 493201.286
NWE Norwest Energy NL 0.8 33.3 261459975 28406802.444
TPD Talon Petroleum 0.4 33.3 193412493 13055368.575
XST Xstate Resources 0.8 33.3 71696658 10867445.388
KEY KEY Petroleum 0.6 33.3 106682396 8855676.567
KTE K2 Energy 5.9 31.1 18500322 13529571.795
SIS Simble Solutions 3.8 31.0 1114519 6909671.428
EGY Energy Tech 15 30.4 26008 19667639.825
LVE Love Group Global 9 30.4 623196 2796857.661
TIG Tigers Realm Coal 1.3 30 6584815 97584926.42
ZEO Zeotech Limited 7 29.6 33156438 75548763.936
HLX Helix Resources 1.4 27.2 34738074 8735319.208
ICI Icandy Interactive 15.5 24 19585200 69557981.125
TAO TAO Commodities 36.5 21.7 973791 25961000.1
PGY Pilot Energy 3.5 20.7 4116797 5994634.776
AVL Aust Vanadium 1.8 20 32971820 43952382.21
EDE Eden Inv 3 20 19786258 51942459.075
FGO Fargo Enterprises 0.3 20 4092784 2964391.7575
GLV Global Oil & Gas 1.2 20 30693074 6536248.06
TAS Tasman Resources 4.8 20 2253404 24445579.12
OVN Oventus Medical 25.5 18.6 142414 34026000